Dr. Francis Lacombe explains how Beckman Coulter's HematoFlow* and CytoDiff* were instrumental to a recent study that tracked blast decrease rates in acute myeloid leukemia (AML) patients. In addition to the results of this study, Dr. Lacombe will discuss:
- Limitations of the existing reference method (microscopy) for WBC differential
- Key functionality and benefits of HematoFlow and CytoDiff
- How CytoDiff enables efficient, accurate blast count
Presenter: Francis Lacombe, M.D., Ph.D., is head of the hematology/automation laboratory and director of flow cytometry at the Université Hôpital, Haut-Lévêque, Pessac, France. Dr. Lacombe serves as a member of Société Française d'Hématologie, Groupe Français d'Hématologie Cellulaire, Association Française de Cytométrie and Groupe d'Etude Immunologique des Leucémies; a counselor for the International Society for Analytical Cytology and the International Society for Laboratory Hematology; an advisor to the CLSI Hematology committee; and an ICSH member.
*CE marked; not available for sale in the U.S and other geographies.